Part I: Differentiated Thyroid Cancer: Initial Management
1.A Patient with a Single Thyroid Nodule Suspicious for Follicular Neoplasm According to the Bethesda System for Reporting Thyroid Cytopathology: Molecular Evaluation
2.A Young Patient with Intrathyroidal Papillary Thyroid Cancer and Family History of Differentiated Thyroid Cancer
3.A Case of a Small (1-2 cm) Papillary Thyroid Cancer in a Young Patient: Lobectomy Versus Total Thyroidectomy
4.A Patient with Papillary Microcarcinoma Undergoing Active Surveillance
5.Completion Thyroidectomy in a Patient with Low-Risk Papillary Cancer
6.A Papillary Thyroid Cancer with Minimal Extra-thyroidal Extension
7.A small Papillary Thyroid Cancer with angioinvasion
8.A patient with a pathological diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP)
9. Papillary Thyroid Cancer with Central Neck Lymph Node Metastases
10.A Patient with a Large Minimally Invasive Follicular Thyroid Cancer
11.A Child with Papillary Thyroid Cancer and Locally Advanced Disease but No Distant Metastasis
Part II: Differentiated Thyroid Cancer: Postoperative Follow-Up
12.A Patient with Papillary Thyroid Cancer and Biochemical Evidence of Disease at the One-Year Follow-Up Visit
13.A Patient with Low Risk Papillary Thyroid Cancer Who Has Undergone a Lobectomy: Monitoring for Recurrent Disease and Assessment of Thyroid Function.-14.A Patient with Papillary Thyroid Carcinoma and Biochemical Evidence of Disease at Follow-Up Visits with Increasing Serum Tg Values at the Follow-Up Assessments
15.A Young Patient with Recurrent Lymph Node Involvement: Imaging, Cytology, and Thyroglobulin Washout
Part III: Differentiated Thyroid Cancer: Special Issues
16. Papillary Thyroid Carcinoma Diagnosed During Pregnancy
17. Risks of Thyroid Hormone Suppression for Differentiated Thyroid Cancer in the Elderly
18.A Case with Postsurgical Hypoparathyroidism
19.A Patient with Postsurgical Recurrent Laryngeal Nerve Damage and Nerve Monitoring
Part IV: Differentiated Thyroid Cancer: Managing higher risk patients
20.A Case of Papillary Thyroid Cancer Without Aggressive Histological Features with Nodal Metastases Detected During Follow-Up in a Younger Patient
21.A Patient with a Large Hürthle Cell Carcinoma of the Thyroid and Nodal Metastases
22.A Case of a Large, Invasive PTC with Gross Residual Disease (pT4) After Surgery
23.A Patient with Papillary Carcinoma of the Thyroid with Elevated Serum Thyroglobulin but Negative Imaging Studies
24.A Young Child with Papillary Thyroid Cancer and Metastatic Pulmonary Disease: Role of Radioactive Iodine Therapy in Children
25.A Patient with Bone Metastases from Follicular Carcinoma of the Thyroid
26. Radioiodine Therapy in Lactating Women with Higher-Risk Differentiated Thyroid Cancer
Part V: Differentiated Thyroid Cancer: Beyond Radioactive Iodine Therapy
27.A Case of a Patient with Radioactive Iodine Refractory Differentiated Thyroid Cancer with Progressive Neck Disease (Latero-cervical Lymph Nodes) and Stable, Small Lung Metastases
28. A Case of a Patient with High Risk Papillary Thyroid Cancer With Gross Residual Disease after Initial Thyroidectomy: Role of External Beam Radiotherapy
29. RAI-Refractory Differentiated Thyroid Cancer with Multiple Organ Progressive Disease
30. RAI-Refractory Differentiated Thyroid Cancer and Lung Lesions Causing Bleeding
31.A Patient with Follicular Thyroid Cancer and a Painful Bone Metastases at Risk for Pathologic Fracture
32. Differentiated Thyroid Cancer and Brain Metastases
33. RAI-Refractory, Advanced Differentiated Thyroid Cancer Receiving Tyrosine Kinase Inhibitor Treatment: Checking for Drug-Drug Interactions
Part VI: Medullary Thyroid Cancer
34. Management of Postoperative Hypercalcitoninemia in MTC
35.A Patient with Metastatic Medullary Thyroid Carcinoma (MTC) and Tumor-Related Diarrhea
36. Clinical Management of a Patient with a Locally Recurrent Medullary Thyroid Cancer and Asymptomatic Slowly Progressing Distant Metastases
37.A Patient with an Advanced Medullary Thyroid Cancer and Progressive, Symptomatic Distant Metastases: When to Start Systemic Therapy
38. Medical Treatment Decision-Making for Advanced, Progressive Medullary Thyroid Cancer
39. Screening Leading to Diagnosis of C-Cell Hyperplasia
40. Increased Basal Calcitonin in Nodular Goiter: Is It Micromedullary Thyroid Cancer?
41. Timing and Extent of Surgery for a Pediatric Patient with Hereditary MTC and Positive Screening for the S891A RET Mutation
Part VII: Anaplastic Thyroid Cancer
42. Anaplastic Thyroid Cancer: Surgery or Not in Locally Advanced Disease
43.A Patient with BRAFV600E-mutated Anaplastic Thyroid Cancer with Metastatic Disease.